Journal of Jilin University(Medicine Edition) ›› 2022, Vol. 48 ›› Issue (2): 540-545.doi: 10.13481/j.1671-587X.20220235
• Review • Previous Articles Next Articles
Received:
2021-03-13
Online:
2022-03-28
Published:
2022-05-10
CLC Number:
1 | 孟琴琴,郭美亮,袁定芬, 等. SGK1功能的研究进展及临床意义 [J]. 医学综述, 2020, 26 (3): 427-432. |
2 | VASUDEVAN K M, BARBIE D A, DAVIES M A, et al. AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer [J]. Cancer Cell, 2009, 16 (1): 21-32. |
3 | BRUHN M A, PEARSON R B, HANNAN R D,et al. AKT-independent PI3-K signaling in cancer-emerging role for SGK3 [J]. Cancer Manag Res, 2013, 5(5): 281-292. |
4 | AHMED M, FEZAI M, UZCATEGUI N L, et al. SGK3 Sensitivity of Voltage Gated K+ Channel Kv1.5 (KCNA5) [J]. Cell Physiol Biochem, 2016,38(1): 359-367. |
5 | LANG F, BöHMER C, PALMADA M, et al. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms [J]. Physiol Rev, 2006, 86 (4): 1151-1178. |
6 | HIRAOKA D, HOSODA E, CHIBA K, et al. SGK phosphorylates Cdc25 and Myt1 to trigger cyclin B–Cdk1 activation at the meiotic G2/M transition [J]. Cell Biol, 2019, 218 (11): 3597-3611. |
7 | LIU M, CHEN L, CHAN T H, et al. Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma [J]. Hepatology, 2012, 55 (6): 1754-1765. |
8 | HOU M, LAI Y, HE S, et al. SGK3 (CISK) may induce tumor angiogenesis (Hypothesis) [J]. Oncol Lett, 2015, 10 (1): 23-26. |
9 | LANG F, COHEN P. Regulation and physiological roles of serum- and glucocorticoid-induced protein kinase isoforms [J]. Sci STKE, 2001, 2001 (108): re17. |
10 | 郭红艳,孙晓杰,刘秀财,等 .蛋白激酶SGK3过表达对乳腺癌细胞株MDA-MB-231影响的研究[J].中华肿瘤防治杂志,2016,23 (24):1601-1606. |
11 | GONG G Q, WANG K, DAI X C,et al. Identification, structure modification, and characterization of potential small-molecule SGK3 inhibitors with novel scaffolds [J]. Acta Pharmacol Sin, 2018, 39 (12): 1902-1912. |
12 | BASNET R, GONG G Q, LI C, et al. Serum and glucocorticoid inducible protein kinases (SGKs):a potential target for cancer intervention [J]. Acta Pharm Sin B, 2018, 8 (5): 767-771. |
13 | CHEN Y, SUN Z, QI M, et al. INPP4B restrains cell proliferation and metastasis via regulation of the PI3K/AKT/SGK pathway [J]. J Cell Mol Med,2018,22(5): 2935-2943. |
14 | MALIK N, MACARTNEY T, HORNBERGER A, et al. Mechanism of activation of SGK3 by growth factors via the Class 1 and Class 3 PI3Ks [J]. Biochem J, 2018, 475 (1): 117-135. |
15 | BRUHN M A, PEARSON R B, HANNAN R D,et al. Second AKT: the rise of SGK in cancer signalling[J]. Growth Factors, 2010, 28 (6): 394-408. |
16 | LIEN E C, DIBBLE C C, TOKER A. PI3K signaling in cancer: beyond AKT [J]. Curr Opin Cell Biol, 2017, 45 (45): 62-71. |
17 | BAGO R, SOMMER E, CASTEL P, et al. The hVps34-SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growth [J]. EMBO J, 2016, 35 (17): 1902-1922. |
18 | VIRBASIUS J V, SONG X, POMERLEAU D P,et al. Activation of the Akt-related cytokine-independent survival kinase requires interaction of its phox domain with endosomal phosphatidylinositol 3-phosphate [J]. Proc Natl Acad Sci U S A, 2001,98(23): 12908-12913. |
19 | XU J, LIU D, GILL G, et al. Regulation of cytokine-independent survival kinase (CISK) by the Phox homology domain and phosphoinositides [J]. J Cell Biol, 2001, 154 (4): 699-705. |
20 | SCHULTE L A, LÓPEZ-GIL J C, SAINZ B Jr, et al. The Cancer Stem Cell in Hepatocellular Carcinoma[J]. Cancers (Basel), 2020, 12 (3): 684. |
21 | MITRA A, MISHRA L, LI S. EMT, CTCs and CSCs in tumor relapse and drug-resistance [J]. Oncotarget, 2015, 6 (13): 10697-10711. |
22 | HOSODA E, HIRAOKA D, HIROHASHI N, et al. SGK regulates pH increase and cyclin B-Cdk1 activation to resume meiosis in starfish ovarian oocytes[J]. Cell Biol, 2019, 218 (11): 3612-3629. |
23 | KONG X, LIU F, GAO J. MiR-155 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells through the activation of PI3K/SGK3/β-catenin signaling pathways[J]. Oncotarget, 2016, 7(40): 66051-66060. |
24 | CAO H, XU Z, WANG J, et al. Functional role of SGK3 in PI3K/Pten driven liver tumor development [J]. BMC Cancer, 2019,19(1):343. |
25 | TESSIER M, WOODGETT J R. Serum and glucocorticoid-regulated protein kinases: variations on a theme [J]. J Cell Biochem, 2006, 98 (6): 1391-1407. |
26 | LIU F, WU X, QIAN Y, et al. PIK3C3 regulates the expansion of liver CSCs and PIK3C3 inhibition counteracts liver cancer stem cell activity induced by PI3K inhibitor [J]. Cell Death Dis, 2020, 11 (6): 427. |
27 | LIU F, WU X, JIANG X, et al. Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3β/β-catenin signalling [J]. J Exp Clin Cancer Res, 2018, 37 (1): 122. |
28 | WU M, HUANG C, HUANG X, et al. MicroRNA-144-3p suppresses tumor growth and angiogenesis by targeting SGK3 in hepatocellular carcinoma [J]. Oncol Rep, 2017, 38 (4): 2173-2181. |
29 | WANG Y, ZHOU D, PHUNG S, et al. SGK3 sustains ERα signaling and drives acquired aromatase inhibitor resistance through maintaining endoplasmic reticulum homeostasis [J]. Proc Natl Acad Sci U S A, 2017,114 (8):E1500-E1508. |
30 | TOVELL H, TESTA A, ZHOU H, et al. Design and Characterization of SGK3-PROTAC1, an isoform specific SGK3 kinase PROTAC degrader [J]. ACS Chem Biol, 2019, 14 (9): 2024-2034. |
31 | SUN X, LIU X, LIU B O, et al. Serum- and glucocorticoid-regulated protein kinase 3 overexpression promotes tumor development and aggression in breast cancer cells [J]. Oncol Lett, 2016, 12 (1): 437-444. |
32 | WANG Y, ZHOU D, PHUNG S, et al. SGK3 is an estrogen-inducible kinase promoting estrogen-mediated survival of breast cancer cells [J]. Mol Endocrinol, 2011, 25 (1): 72-82. |
33 | XU J, LIAO L, QIN J, et al. Identification of Flightless-I as a substrate of the cytokine-independent survival kinase CISK[J].J Biol Chem,2009,284(21):14377-14385. |
34 | WANG H, HUANG F, ZHANG Z, et al. Feedback activation of SGK3 and AKT contributes to rapamycin resistance by reactivating mTORC1/4EBP1 axis via TSC2 in breast cancer [J]. Int J Biol Sci, 2019, 15 (5): 929-941. |
35 | SHERK A B, FRIGO D E, SCHNACKENBERG C G,et al. Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic [J]. Cancer Res, 2008, 68 (18): 7475-7483. |
36 | WANG Y, ZHOU D, CHEN S. SGK3 is an androgen-inducible kinase promoting prostate cancer cell proliferation through activation of p70 S6 kinase and up-regulation of cyclin D1[J].Mol Endocrinol,2014,28 (6): 935-948. |
37 | SHARMA N L, MASSIE C E, RAMOS-MONTOYA A,et al. The androgen re-ceptor induces a distinct transcriptional program in castration-re-sistant prostate cancer in man [J]. Cancer Cell, 2013, 23 (1): 35-47. |
38 | NALAIRNDRAN G, HASSAN ABDUL RAZACK A, MAI C W,et al. Phosphoinositide-dependent Kinase-1 (PDPK1) regulates serum/glucocorticoid-regulated Kinase 3 (SGK3) for prostate cancer cell survival [J]. J Cell Mol Med, 2020, 24 (20): 12188-12198. |
39 | WANG Y, XU W, ZHOU D, et al. Coordinated regulation of serum- and glucocorticoid-inducible kinase 3 by a C-terminal hydrophobic motif and Hsp90-Cdc37 chaperone complex [J]. J Biol Chem, 2014, 289 (8): 4815-4826. |
40 | LIU H, LI C, SHEN C, et al. MiR-212-3p inhibits glioblastoma cell proliferation by targeting SGK3 [J]. J Neurooncol, 2015, 122 (3): 431-439. |
41 | JU C, ZHOU R, SUN J, et al. LncRNA SNHG5 promotes the progression of osteosarcoma by sponging the miR-212-3p/SGK3 axis [J]. Cancer Cell Int, 2018, 18 (18): 141. |
42 | FAN X R, ZHANG Z Y, WANG R H, et al. MiR-376a functions as tumor suppressor by targeting SGK3 in renal cell carcinoma [J]. Eur Rev Med Pharmacol Sci, 2019, 23 (9): 3726-3732. |
43 | ZHENG H, WU L, WANG X, et al. Risk of nasopharyngeal carcinoma associated with single nucleotide polymorphisms in the microRNA binding site of SGK3[J].Genet Test Mol Biomarkers,2020,24(8): 508-519. |
44 | MALIK N, NIRUJOGI R S, PELTIER J, et al. Phosphoproteomics reveals that the hVPS34 regulated SGK3 kinase specifically phosphorylates endosomal proteins including Syntaxin-7, Syntaxin-12, RFIP4 and WDR44 [J]. Biochem J, 2019, 476 (20): 3081-3107. |
[1] | . Research progress in effect of histone demethylase in tumor progression [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 528-536. |
[2] | Ye YUAN,Jinbao ZHUANG,Xu SHI,Changyuan LI. Influence of PGE2 on PD-1 expression in infiltrating T lymphocytes in non-small cell lung cancer tissue and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 249-256. |
[3] | LI Shengnan, WANG Mengxu, HU Weidong, CHEN Shaofeng, CHEN Xinglan, LI You. Construction and identification of miR-186 overexpression lentiviral vector [J]. Journal of Jilin University(Medicine Edition), 2019, 45(05): 997-1002. |
[4] | . Research progress in role of mechanosensitive ion channel protein Piezo in mechanical transduction [J]. Journal of Jilin University(Medicine Edition), 2019, 45(03): 725-730. |
[5] | . Research progress in function of cell division cycle protein Cdc14A [J]. Journal of Jilin University(Medicine Edition), 2018, 44(05): 1105-1108. |
[6] | SHI Xu, YU Xin, QU Xinglong, CAO Yang, ZHANG Guangjuan, LI Changyuan. Effects of hypoxia and its downstream factor mirRNA-145 on differentiation of umbilical cord mesenchymal stem cells into type Ⅱ alveolar epithelial cells [J]. Journal of Jilin University(Medicine Edition), 2018, 44(05): 935-942. |
[7] | XI Yanli, XU Na, LI Shu, WANG Di, WANG Shuran, NIU Fenglan. Inhibitory effect of gallic acid on proliferation of human non-small cell lung cancer A549 cells [J]. Journal of Jilin University Medicine Edition, 2016, 42(06): 1092-1098. |
[8] | ZHANG Yanqiu, WANG Chunsheng, WANG Kunzheng, JIANG Zhaolong. Influence of long term application glucocorticoid on expressions of HMGB1,RAGE,OPG and RANKL in bone tissue of rats [J]. Journal of Jilin University Medicine Edition, 2015, 41(05): 907-913. |
[9] | PAN Tao, GUO Caixia, JIN Minghua, LIU Xiaomei, LIU Ying, DU Haiying, SUN Zhiwei. Cytotoxicity of SiO2 nanoparticles on liver HL-7702 cells [J]. Journal of Jilin University Medicine Edition, 2015, 41(05): 885-890. |
[10] | . Advance research on new calcium channels TRPV5 and TRPV6 [J]. Journal of Jilin University Medicine Edition, 2013, 39(3): 634-637. |
[11] | ZHOU Jia-qi,LU Jia-rui*,XU Hua,HAN Fang,SUN Yan-bo. Detection of aminoglycoside modifying enzyme genes in gram-negative bacilli from some hospitals in Changchun area [J]. Journal of Jilin University Medicine Edition, 2013, 39(2): 405-409. |
[12] | . Expressions |of Galectin-3 and integrin ανβ3 mRNA in glioma cells and their significances [J]. J4, 2012, 38(5): 973-976. |
[13] | ZHANG Hong-mei,LIANG Mei,LIU Ping,WU Ting-ting,GUO Shu-liang. Interaction between mycobacteriophage D29 and macrophages and its mechanism [J]. J4, 2012, 38(2): 230-236. |
[14] | LIU Yue,LI Jing-hua,SHI Hong-yan,WEN Jian-ping,SUN Yan-bo. Biological characteristics of enterohemorrhagic E. coliO157-specific bacteriophages isolated from raw sewage [J]. J4, 2012, 38(1): 79-83. |
[15] | LIANG-Yu,LI-Na,XU Hong-mei,HE Jin. Application of FISH technique in chromosome detection for missed abortion and dead fetus tissues [J]. J4, 2012, 38(1): 127-130. |
|